Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AA
NCT07532408
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Aplastic Anemia
Interventions
DRUG:
Romiplostim N01
Sponsor
Peking Union Medical College Hospital